Why MED Stock surged +3.13% Today — RQD Quant Desk Flash

MED scores 50 out of 100 for a letter grade of D, with the verdict label "Roarable Sell — Underperform / Distribution Warning." The five pillars are:

• Fundamental Cash Engine: 12 / 20. this pillar reflects ROIC of -10.2% and an FCF yield of 0.91%. Negative return on invested capital means the business is currently not earning back its capital base, and a sub-1% FCF yield indicates limited free cash generation relative to the market value.
• Whale / 13F Flow: 12 / 20. the pillar reflects institutional accumulation and options positioning.
• Insider Conviction: 5 / 20. this is the weakest pillar and reflects SEC Form 4 and Congressional PTR cluster flow.
• Macro Regime Fit: 10 / 20. the pillar cites a beta of 1.0 and sector sensitivity. A beta of 1.0 implies market-level sensitivity to broad moves, without a defensive or aggressive tilt.
• Forensic Balance Sheet: 11 / 20. the pillar reflects Altman Z 4.71, Piotroski F 5/9, and Debt/Equity 0.5. These metrics point to a balance sheet that is more stable than the earnings trajectory alone would suggest.

For a prospective investor evaluating the stock today, the composite picture is one of weak profitability and cash generation offset in part by a relatively sound balance-sheet profile. The upside drivers the data supports are the forensic balance sheet and the institutional-flow pillar; the headwinds are negative ROIC, a thin FCF yield, and weak insider conviction. The rating is a descriptive summary of the data provided and is not a recommendation.

Is a NYSE-listed issuer in the Consumer Staples sector, operating in Packaged Foods, with a market capitalization of $0.1B. Per the market data, the company reports a gross margin of 71.3%.

Revenue declined from $1.07B in FY 2023 to $385.8M in FY 2025, and the company moved from positive operating income in FY 2023 and FY 2024 to an operating loss of -$14.2M in FY 2025. Per the market data, operating margin is -3.7%, net margin is -4.9%, and ROIC is -10.2%. The Altman Z-Score is 4.71 and the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. Reported cash was $89.3M at FY 2025.

• 🐂 Primary Bull Case: The forensic balance sheet scores 11 of 20 with an Altman Z of 4.71 and a Piotroski F of 5/9, indicating a more stable financial profile than the earnings trend alone suggests. With Fundamental Cash Engine at 12/20 (ROIC -10.2%, FCF yield 0.91%) and Institutional Whale Flow at 10/20, sustained execution supports upside toward the top of the $9.22 – $13.45 52-week range.
• 🐻 Primary Bear Case: Revenue fell from $1.07B in FY 2023 to $385.8M in FY 2025 while operating income turned to -$14.2M, with ROIC at -10.2% and an FCF yield of 0.91%. Investors must weigh current valuation against -3.7% operating margins and a 1.00 macro beta if sector demand softens.

Upstream and downstream dependencies, sector correlations, and second-order bottlenecks cannot be mapped from the source data. The only sector context available is the classification as Consumer Staples / Packaged Foods.

• Key Question #1: What are the company's P/E (TTM), forward P/E, and EV/EBITDA, and how do they compare with peers?
• Key Question #2: What drove the revenue decline from $1.07B in FY 2023 to $385.8M in FY 2025, and is the trend continuing into the current period?
• Key Question #3: What is the company's debt position by period, given that debt is listed as N/A throughout the financials?